Joerg Kaufmann

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Use of VEGFR1 as a biomarker
- Patent number 9,133,515
- Issue date Sep 15, 2015
- Silence Therapeutics GmbH
- Klaus Giese
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genes differentially expressed in breast cancer
- Patent number 8,236,928
- Issue date Aug 7, 2012
- Novartis Vaccines and Diagnostics, Inc.
- Joerg Kaufmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Genes differentially expressed in breast cancer
- Patent number 7,605,246
- Issue date Oct 20, 2009
- Novartis Vaccines and Diagnostics, Inc.
- Joerg Kaufmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Genes differentially expressed in breast cancer
- Patent number 7,081,517
- Issue date Jul 25, 2006
- Chiron Corporation
- Joerg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CIF130 inhibits cell cycle progression
- Patent number 6,589,745
- Issue date Jul 8, 2003
- Chiron Corporation
- Joerg Kaufmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for determining metastatic potential of breast cancer cells...
- Patent number 6,566,063
- Issue date May 20, 2003
- Chiron Corporation
- Joerg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
USE OF VEGFR1 AS A BIOMARKER
- Publication number 20150368650
- Publication date Dec 24, 2015
- Silence Therapeutics GMBH
- KLAUS GIESE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF VEGFR1 AS A BIOMARKER
- Publication number 20140179755
- Publication date Jun 26, 2014
- KLAUS GIESE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Genes Differentially Expressed in Breast Cancer
- Publication number 20130196314
- Publication date Aug 1, 2013
- Novartis Vaccines and Diagnostics, Inc.
- Joerg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Factor Involved in Metastasis and Uses Thereof
- Publication number 20100285038
- Publication date Nov 11, 2010
- ANKE KLIPPEL-GIESE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Factor involved in metastasis and uses thereof
- Publication number 20060240022
- Publication date Oct 26, 2006
- Atugen AG
- Anke Klippel-Giese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Genes differentially expressed in breast cancer
- Publication number 20060216748
- Publication date Sep 28, 2006
- Chiron Corporation
- Joerg Kaufmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of double-stranded ribonucleic acid for inducing cell lysis
- Publication number 20050043263
- Publication date Feb 24, 2005
- Atugen AG
- Klaus Giese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CIF130 inhibits cell cycle progression
- Publication number 20030113791
- Publication date Jun 19, 2003
- Chiron Corporation
- Joerg Kaufmann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Genes differentially expressed in breast cancer
- Publication number 20030017517
- Publication date Jan 23, 2003
- Chiron Corporation
- Joerg Kaufmann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CIF130 inhibits cell cycle progression
- Publication number 20020143154
- Publication date Oct 3, 2002
- Chiron Corporation
- Joerg Kaufmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Genes differentially expressed in breast cancer
- Publication number 20020004239
- Publication date Jan 10, 2002
- Joerg Kaufmann
- C07 - ORGANIC CHEMISTRY

Joerg Kaufmann

Person

Patents Grantslast 30 patents

Use of VEGFR1 as a biomarker

Genes differentially expressed in breast cancer

Genes differentially expressed in breast cancer

Genes differentially expressed in breast cancer

CIF130 inhibits cell cycle progression

Methods for determining metastatic potential of breast cancer cells...

Patents Applicationslast 30 patents

USE OF VEGFR1 AS A BIOMARKER

USE OF VEGFR1 AS A BIOMARKER

Genes Differentially Expressed in Breast Cancer

Factor Involved in Metastasis and Uses Thereof

Factor involved in metastasis and uses thereof

Genes differentially expressed in breast cancer

Use of double-stranded ribonucleic acid for inducing cell lysis

CIF130 inhibits cell cycle progression

Genes differentially expressed in breast cancer

CIF130 inhibits cell cycle progression

Genes differentially expressed in breast cancer